Analyst consensus rating

Prestige Consumer Healthcare Analyst Rating: Buy

Direct answer

Prestige Consumer Healthcare's consensus rating is Buy.

5 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $66.20.
Forecast evidence checked November 18, 2026.

Get free Prestige Consumer Healthcare email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Current price
$48.22
Average price target
$66.20
High price target
$75.00
Low price target
$51.00
Low target gap
+5.8%
Target upside
+37.3%
High target gap
+55.5%
Target range width
49.8%
Consensus rating
Buy
Analysts
5
Evidence date
November 18, 2026
Valid through
November 25, 2026

Read the frequently asked questions.

What is the analyst consensus rating for Prestige Consumer Healthcare?

Prestige Consumer Healthcare has a verified Buy consensus. The same dataset has an average price target of $66.20.

How far are Prestige Consumer Healthcare's low and high targets from the recorded price?

The low target implies +5.8%, while the high target implies +55.5%.

How many analysts are included in Prestige Consumer Healthcare's consensus?

The verified consensus includes 5 analysts.

How is Prestige Consumer Healthcare's target upside or downside calculated?

The average target of $66.20 is divided by the recorded price of $48.22, then one is subtracted to produce +37.3%. This does not guarantee a future return.

When was Prestige Consumer Healthcare's analyst forecast verified?

The data was verified on 2026-11-18. The dataset is valid through 2026-11-25.